LABELING REQUIREMENTS. Following the Closing, Buyer shall promptly and at its own expense use all reasonable efforts to obtain such FDA approvals necessary for Buyer Labeling for the Product to be manufactured after the Closing and, promptly comply with such FDA approvals upon receipt thereof.
Appears in 1 contract
Samples: Asset Purchase Agreement (First Horizon Pharmaceutical Corp)
LABELING REQUIREMENTS. Following the Closing, Buyer Buyers shall promptly and at its their own expense and as expeditiously as possible use all commercially reasonable efforts to obtain such FDA approvals necessary for Buyer Labeling for the Product to be manufactured after the Closing and, promptly comply with such FDA approvals upon receipt thereofClosing.
Appears in 1 contract
LABELING REQUIREMENTS. Following the Closing, Buyer shall promptly and at its own expense and as expeditiously as possible use all reasonable efforts to obtain such FDA approvals necessary for Buyer Labeling for the Product to be manufactured after the Closing and, promptly comply with such FDA approvals upon receipt thereofClosing.
Appears in 1 contract
Samples: Asset Purchase Agreement (Valeant Pharmaceuticals International)
LABELING REQUIREMENTS. Following the Closing, Buyer shall promptly and shall, at its own expense and as expeditiously as possible, use all reasonable efforts to obtain such FDA approvals necessary for Buyer Labeling for the Product Products to be manufactured after the Closing and, promptly comply with such FDA approvals upon receipt thereof.
Appears in 1 contract
Samples: Asset Purchase Agreement (Accentia Biopharmaceuticals Inc)